Beyond The Numbers: 8 Analysts Discuss Cigna Stock
CVS, Humana Dip Amid New Mental Health Guidelines, Leerink Note
Cigna Analyst Ratings
The Cigna Group (NYSE:CI) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
RBC Capital Maintains The Cigna Group(CI.US) With Buy Rating, Maintains Target Price $384
The Cigna Group's "Community Vitality Project" Donates $75,000 to Nonprofits Through Program Encouraging Fitness and Community Engagement
Cigna to Offer Biosimilar to J&J's Arthritis Drug Stelara at $0 Out-of-pocket
Cencora Lifts FY24 Earning Guidance
Evernorth Announces Another Step Forward in Lowering Drug Prices by Making a Stelara Biosimilar Available at $0 Out of Pocket for Patients Early Next Year
BofA's Global Contenders and Defenders List
Express News | Cigna: Reaffirm Projected FY Consolidated Adjusted Income From Operations on a per Share Basis of at Least $28.40 per Share
The Cigna Group To Go Ex-Dividend On September 4th, 2024 With 1.4 USD Dividend Per Share
Dividend Roundup: Waste Management, Deere, McDonald's, Lockheed Martin, and More
Express News | Celltrion USA Partners With Express Scripts and Cigna Healthcare to Expand Access to Zymfentra® (Infliximab-Dyyb), the First and Only FDA-Approved Subcutaneous Infliximab on Their Medical Benefit Formulary
Celltrion USA Partners With Express Scripts and Cigna Healthcare to Expand Access to ZYMFENTRA (Infliximab-dyyb), the First and Only FDA-approved Subcutaneous Infliximab on Their Medical Benefit Formulary
US House Committee Sends Warning Letters to CVS, Cigna, UnitedHealth
8 Dividend Growth Stocks for Falling Interest Rates
Cigna PBM Express Scripts to Remove Humira From Many Formularies
Here's How Much $1000 Invested In Cigna 5 Years Ago Would Be Worth Today
Express News | Watching Cencora; Traders Circulate Unconfirmed Analyst Comments Suggesting The Co Has Lost Its Partnership With Cigna To Distribute Branded Humira; Cigna To Transition Distribution Through Its Specialty Distributor Curascript Starting January 2025